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Abstract
The physiological demands of marathon and ultra-marathon running are substantial, affecting multiple body systems. There 
have been several reviews on the physiological contraindications of participation; nevertheless, the respiratory implications 
have received relatively little attention. This paper provides an up-to-date review of the literature pertaining to acute pulmo-
nary and respiratory muscle responses to marathon and ultra-marathon running. Pulmonary function was most commonly 
assessed using spirometry, with infrequent use of techniques including single-breath rebreathe and whole-body plethysmog-
raphy. All studies observed statistically significant post-race reductions in one-or-more metrics of pulmonary function, with 
or without evidence of airway obstruction. Nevertheless, an independent analysis revealed that post-race values rarely fell 
below the lower-limit of normal and are unlikely, therefore, to be clinically significant. This highlights the virtue of healthy 
baseline parameters prior to competition and, although speculative, there may be more potent clinical manifestations in 
individuals with below-average baseline function, or those with pre-existing respiratory disorders (e.g., asthma). Respiratory 
muscle fatigue was most commonly assessed indirectly using maximal static mouth-pressure manoeuvres, and respiratory 
muscle endurance via maximum voluntary ventilation  (MVV12). Objective nerve-stimulation data from one study, and oth-
ers documenting the time-course of recovery, implicate peripheral neuromuscular factors as the mechanism underpinning 
such fatigue. Evidence of respiratory muscle fatigue was more prevalent following marathon compared to ultra-marathon, 
and might be a factor of work rate, and thus exercise ventilation, which is tempered during longer races. Potential implica-
tions of respiratory muscle fatigue on health and marathon/ultra-marathon performance have been discussed, and include a 
diminished postural stability that may increase the risk of injury when running on challenging terrain, and possible respira-
tory muscle fatigue-induced effects on locomotor limb blood flow. This review provides novel insights that might influence 
marathon/ultra-marathon preparation strategies, as well as inform medical best-practice of personnel supporting such events.
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Key Points 
Pulmonary function (via spirometry) has been widely 
assessed following marathon and ultra-marathon, as has 
respiratory muscle fatigue (indirectly, via maximal static 
mouth-pressure manoeuvres).
Both event types are sufficient to provoke post-race 
decreases in pulmonary function in the range of 10–15% 
(with or without evidence of airway obstruction), and 
respiratory muscle fatigue in the range of 15–25%.
Post-race decreases in pulmonary function rarely reach 
clinical significance (i.e., values tend to remain within 
the lower-limits of normal), but implications may be 
more severe for individuals with pre-existing respiratory 
disorders or below-average baseline function.
1 Introduction
The marathon footrace (42.2 km) was once considered 
among the greatest feats of human endurance [1] and, as a 
result, marathon running has been used widely as a model to 
investigate the limits of physiological function. The last few 
decades have seen an increased popularity of the ultra-mar-
athon; defined as any footrace that exceeds the traditional 
marathon [2] and that typically lasts for > 6 h [3]. Most 
ultra-marathons take place over distances ranging from 50 
to 160 km in a single stage, and up to 3100 km in multi-stage 
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events. Races are contested the world over, often in remote 
locations and in extremes of temperature and altitude. The 
physiological demands of marathon and ultra-marathon 
events are substantial, affecting multiple body systems, thus 
providing an excellent model with which to study the adap-
tive responses to extreme load and stress [2].
In healthy humans, the respiratory system is considered 
to have sufficient capacity to meet the endurance exercise 
demands on pulmonary ventilation and gas exchange. For 
example, exercise ventilation of untrained subjects demands 
< 10% of both maximal oxygen uptake (VȮ2max) and maxi-
mum cardiac output (Q ̇) [4, 5], and changes in intrathoracic 
pressure resulting from contractions of the respiratory mus-
cles approximate only 40–50% of their pressure-generating 
potential [6]. Moreover, exercise-induced decreases in arte-
rial  O2 saturation are due predominantly to factors inde-
pendent of the respiratory system (i.e., metabolic acidosis 
and hyperthermia, causing a rightward shift of the oxyhae-
moglobin dissociation curve [7, 8]). Despite this apparent 
respiratory reserve, there are several mechanisms by which 
long-distance running might compromise pulmonary and/
or respiratory-muscle function in healthy subjects. First, 
exercise is associated with airway cooling and/or dehy-
dration and increased contact of the airway with pollut-
ing substances; consequently, potential activation of local 
and systemic inflammatory responses may result in airway 
obstruction, and negatively influence lung function (for 
review, see [9]). Second, marathon running has been asso-
ciated with a mild, transient, post-race pulmonary oedema 
[10]. Although the prevalence and potential implications of 
pulmonary oedema are still debated, the phenomenon would 
be expected to compress small airways and blood vessels, 
affecting ventilation-perfusion matching [11]. Third, respira-
tory muscle work is a critical determinant of the magnitude 
of inspiratory muscle fatigue [12, 13], and the cardiorespi-
ratory demands of a typical marathon (up to 75% V ̇O2max 
[14]) are likely sufficient to compromise respiratory muscle 
contractile function via reductions in  Ca2+ availability in 
the sarcolemma [15]. Accordingly, there is now a growing 
body of work suggesting that the respiratory demands of 
prolonged endurance exercise may compromise resting pul-
monary function, as well as attenuate the functional work 
capacity of the respiratory muscles, both of which might 
impact on health and endurance performance.
Despite several reviews on the applied physiology of 
endurance running, only one article published in the 1980s 
has reviewed the pulmonary responses to participation [1], 
concluding that marathon running is associated with moder-
ate-to-high levels of pulmonary ventilation (> 80 L∙min−1), 
sufficient to provoke a reduction in post-race lung capac-
ity, and evidence of respiratory muscle fatigue. The only 
contemporary review of the respiratory consequences of 
marathon running [16] offered a discussion of limited scope, 
and omitted most of the literature pertaining to indices of 
pulmonary function. In the last several decades, a number of 
new studies have reported decreased pulmonary function in 
response to marathon and ultra-marathon. Most studies have 
elucidated the time-course of recovery—there are reports on 
data collected both under controlled laboratory conditions 
and in the field, in remote and/or extreme environments, 
and several studies have assessed respiratory responses using 
advanced techniques such as whole-body plethysmography 
and magnetic nerve stimulation. Thus, we now have a more 
robust, mechanistic understanding of the maladaptive res-
piratory responses to marathon and ultra-marathon, and an 
updated review is warranted.
To date, there have been several reviews on the patho-
physiology of ultra-marathon running [17–23]; yet, discus-
sions of the respiratory implications are notably absent. For 
example, Knechtle and Nikolaidis [22] arguably provided the 
most comprehensive summary of ultra-marathon contrain-
dications including: energetic demands; fluid and hydration; 
musculoskeletal damage; organ damage; and haematologi-
cal, endocrine, cardiovascular, bone, digestive, and immune 
responses. The article, however, neglected to address the 
acute and/or chronic respiratory responses to competition. 
In a separate longitudinal analysis of medical issues among 
ultra-marathon runners [23], the prevalence of several res-
piratory-related disorders was discussed (e.g., lung disease, 
exercise-induced asthma, asthma, chronic bronchitis, pul-
monary embolism, and spontaneous pneumothorax), but 
with no data presented on acute and/or chronic pulmonary 
or respiratory muscle function. Data to this effect would be 
helpful in the design of marathon and ultra-marathon train-
ing and preparation strategies, as well as in informing medi-
cal best-practice of personnel supporting the events (i.e., 
medics, race directors, and volunteers). This paper reviews 
the studies pertaining to pulmonary and respiratory mus-
cle responses to marathon and ultra-marathon running, and 
discusses the potential implications of these responses on 
general health and race performance.
2  Methods
This review deals with the responses of the pulmonary sys-
tem (i.e., airflow and gas exchange) and the prevalence of 
respiratory muscle fatigue in marathon and ultra-marathon 
running. Although the marathon race is contested over a 
predetermined distance (i.e., 42.2 km), ‘ultra-marathon’ is 
a broad term comprising races of various distances, e.g., 31 
miles (50 km; Blackwater Trail, Florida, USA) to 100 miles 
(161 km; Ultra-Trail du Mont-Blanc, Alps) in a single-stage, 
and up to 3100 miles (4989 km; Self-Transcendence 3100 
Mile, New York, USA) in multi-stage events. Given the 
relative paucity of data on the acute respiratory responses 
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to ultra-marathon running, there was no restriction on the 
race type considered for inclusion, with the caveat that the 
article assessed responses specifically to ultra-marathon 
(i.e., footraces) and not ultra-endurance racing in general. 
Articles were searched via three online databases (Pubmed, 
MEDLINE, Google Scholar; 1924–2019), and the search-
terms comprised various combinations of the following: 
extreme-endurance; fatigue; lung; marathon; pathophysiol-
ogy; physiology; pulmonary; respiratory; ultra-endurance; 
and ultra-marathon. The reference lists of those articles 
selected for inclusion were manually searched for additional 
literature.
2.1  Inclusion/Exclusion Process
The following inclusion criteria were applied to the origi-
nal abstracts retrieved using the above search-terms: (1) the 
study made a novel contribution to the literature on mara-
thon or ultra-marathon (the latter defined as a race distance 
greater than a marathon) rather than ultra-endurance exer-
cise in general; (2) the study explored aspects of pulmonary 
function and/or respiratory muscle function and/or respira-
tory muscle fatigue within the context of marathon or ultra-
marathon running; (3) the study made comparable pre- and 
post-race assessments of one-or-more aspects of pulmonary 
and/or respiratory muscle function (irrespective of the time-
course of the post-race measures); and (4) the article was 
available in English.
3  Results
A total of 17 articles were originally found, two of which 
were unavailable in English and were, therefore, excluded 
from the summary (Table 1) and additional analyses. Of 
the 15 remaining articles, nine made assessments before/
after a marathon, and six before/after an ultra-marathon; all 
were single-stage races except for one study investigating 
the responses to multiple, consecutive days of marathon 
running. A summary of the main findings of all 15 stud-
ies is shown in Table 1. With respect to pulmonary func-
tion, spirometry was the most widely utilised method (n 
= 12), with several assessments of diffusing capacity (n = 
4) and intrathoracic pressures (n = 2). Respiratory muscle 
fatigue was widely assessed using volitional mouth-pressure 
manoeuvres (n = 6), with only one study using objective 
nerve stimulation techniques. Most studies compared base-
lines measures to those made immediately after the cessa-
tion of exercise (n = 10), with the remaining studies making 
assessments at varying post-race time-points (range 25 min 
- 3 days). Three articles made additional follow-up assess-
ments at 24 h post-race. Finally, on those studies reporting 
a post-race decrease in one-or-more aspects of spirometry, 
additional independent analyses were conducted to elucidate 
if the reductions could be deemed clinically meaningful (i.e., 
fell below the lower-limits of normal; see “Discussion”).
4  Discussion
4.1  Pulmonary Function
Pulmonary function was most commonly assessed via 
spirometry. This physiological test assesses the competency 
with which an individual inspires or expires volumes of air 
as a function of time by requiring the subject to perform 
a series of forced vital capacity (FVC) manoeuvres into a 
mouthpiece; it is a valuable tool for screening general res-
piratory health [24]. An advantage of the technique is that 
spirometric assessments can be made both in the lab and in 
the field using portable equipment. The disadvantages, how-
ever, are that the FVC manoeuvre is volitional, and requires 
a degree of training and subject competency for reproducible 
data to be obtained.
The first study of pulmonary function in response to 
marathon running assessed lung capacity (FVC) in the first 
22 finishers of the 1923 Boston Marathon, finding that the 
post-race values were significantly reduced by 0.8 L (17%) 
[25]. Several years later, pre- and post-race spirometric 
assessments revealed a fall in FVC of 0.7 and 0.9 L imme-
diately following the Swiss marathons of 1927 and 1928, 
respectively [26, 27], thus corroborating the initial obser-
vations. Due to the absence of robust reference standards 
at the time of publication, it was difficult to contextualise 
these early data. Moreover, the mechanistic basis for the 
observations remained unexplored for several decades until 
1979 when Maron et al. [28] tested spirometry and alveolar 
diffusing capacity for carbon monoxide (DL,CO) in 13 run-
ners, before and immediately after the Wisconsin Mayfair 
Marathon; they also made follow-up assessments of the 
individual maximal expiratory flow-volume (MEFV) curves. 
They found that FVC was reduced by ~0.5 L (8.6%), attrib-
utable to an increase in residual volume (RV), but with no 
change in the forced expiratory volume in 1 s  (FEV1) or 
the mean DL,CO. On assessing the post-race MEFV curves, 
the authors identified a diminished FEV in 1–2 seconds 
 (FEV1–2), indicative of a reduction in small airway cali-
bre at lower lung volumes, likely the result of an airway 
obstruction. This would be expected to permit premature 
closure of the airways and reduce FVC. Two years later, 
Mahler and Loke [29] observed a similar post-race fall in 
FVC (~0.6 L = 12.4%) with congruent reductions in  FEV1 
(9.5%) and peak expiratory flow (PEF; 13.7%) immediately 
following a 100-km footrace. The authors also observed a 
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post-race drop in the maximal expiratory flow at 50% of 
FVC  (MEF50), thereby supporting the notion that decreases 
in pulmonary function in this context might be attributable 
to small airway obstruction. The mechanisms underpinning 
this apparent airway obstruction are unclear, although they 
may be associated with a degree of airway inflammation 
(e.g., increased concentrations of polymorphonuclear neu-
trophils), as reported by Bonsignore et al. [30] following 
marathon running. Given that post-marathon nitric oxide 
(NO) concentrations were also elevated, the authors postu-
lated that NO may have modulated the changes in exercise-
associated airway inflammation [30]. Moreover, Araneda 
et al. [31] observed a greater relative increase in pulmonary 
pro-oxidative levels (hydrogen peroxide and nitrogen diox-
ide) following marathon running when compared to either 
half-marathon or 10-km running, thus suggesting that run-
ning time is positively associated with the magnitude of the 
acute post-exercise, pro-oxidative state. Nevertheless, to the 
author’s knowledge, the prevalence and magnitude of air-
way inflammation following ultra-marathon running (i.e., 
exercise of a longer duration and lower intensity) remain to 
be assessed.
Several of the studies on pulmonary function following 
distance running – Maron et al. (marathon) [28], Ross et al. 
(marathon) [32], and Mahler and Loke (ultra-marathon) [29] 
– made their assessments immediately after exercise, with 
follow-up measurements at 24 h post-race, by which time 
parameters had returned to baseline. Critically, both Mahler 
and Loke and Ross et al. made additional assessments at 
2.5 h and 4 h post-race, respectively, by which point val-
ues had partially-recovered. Such a time-course of recovery 
(i.e., a transient decrease in function that recovers within 
a few hours), suggests that pulmonary function may have 
been influenced by a degree of respiratory muscle fatigue 
(see below).
More recently, Vernillo et  al. used the absolute dis-
tance and unique terrain of extreme-endurance exercise as 
an excellent model to assess the adaptive potential of the 
human respiratory system. The researchers assessed spirom-
etry before, during and immediately after a 330-km moun-
tain ultra-marathon [33]. The main findings were congruent 
with the existing data, i.e., significant post-race decreases in 
FVC (9.5%),  FEV1 (9.7%) and PEF (8.7%), but the ratios of 
 FEV1/FVC, and  FEV1/PEF were reasonably well-maintained 
Table 1  A chronological summary of the literature pertaining to pulmonary and respiratory muscle function in response to marathon and ultra-
marathon running
FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, FEF200–1200 flow measured during the exhaled volume between 200–1200 mL 
of air, RV residual volume, DL,CO diffusing capacity of the alveoli for carbon monoxide, DL,NO diffusing capacity of the alveoli for nitric oxide, 
PIF peak inspiratory flow, PEF peak expiratory flow, MEF50 maximum expiratory flow at 50% of the FVC, IC inspiratory capacity, MIP maxi-
mum inspiratory pressure, MEP maximum expiratory pressure, Pdi,IC peak inspiratory transdiaphragmatic pressure, MVV12 maximum voluntary 
ventilation, DM membrane diffusing capacity, CV closing volume, TLim time to the limit of tolerance, Pm,tw mouth twitch-pressure, TLC total 
lung capacity, ↑ increase, ↓ decrease, ↔ no change
Author (s) Date Event Participants Pre/post-race measures Post-race timing
Gordon et al. [25] 1924 Marathon (42.2 km) N = 22 FVC↓ < 5 min
Maron et al. [28] 1979 Marathon (42.2 km) N = 13 (11 male) FVC↓  FEV1↔  FEV1/FVC↑
FEF200–1200↓ RV↑ DL,CO↔
< 5 min; + 24 h
Mahler & Loke [29] 1981 Ultra-marathon (100 km) N = 15 FVC↓  FEV1↓  FEV1/FVC↔ PEF↓  MEF50↓ < 15 min
Loke et al. [34] 1982 Marathon (42.2 km) N = 4 FVC↔  FEV1↔ PEF↔ IC↔ MIP↓ MEP↓ 
 Pdi,IC↓  MVV12↓
Data unavailable
Miles et al. [35] 1983 Marathon (42.2 km) N = 8 FVC↔  FEV1↑ PEF↔ DL,CO↓ DM↓ CV↑ < 15 min
Warren et al. [37] 1989 Ultra-marathon (24 h) N = 10 FVC↔  FEV1↔ PEF↔ IC↔ MIP↔ MEP↔ 
 (MVV12↓ [after 24 h])
Data unavailable
Manier et al. [36] 1991 Marathon (42.2 km) N = 11 DL,CO↓,  DL,NO↓ ~ 30 min
Chevrolet et al. [49] 1993 Marathon (42.2 km) N = 21 MIP↓ MEP↔  (MVV12↔ [N = 15]) ~ 2.5 h
Ker & Schultz [50] 1996 Ultra-marathon (87 km) N = 10 (8 male) MIP↔  MIPTLim↓ ~ 3 d
Ross et al. [32] 2008 Marathon (42.2 km) N = 9 FVC↔  FEV1↔ PIF↓ PEF↔ MIP↓ MEP↔ < 20 min; + 24 h
Zavorsky et al. [66] 2014 Marathon (42.2 km) N = 36 (24 male) FVC↓  FEV1↔  FEV1/FVC↑ PEF↔  FEF25-75↔ 
(DL,CO↔ DL,NO↔ DM,CO↓ [N = 24])
< 73 min
Wüthrich et al. [40] 2015 Ultra-marathon (110 km) N = 22 FVC↔ FEV1↓ PIF↓ PEF↓ MIP↓ MEP↓ 
 MVV12↓  (Pm,tw↓ [N = 16])
< 90 min
Vernillo et al. [33] 2015 Ultra-marathon (330 km) N = 29 FVC↓  FEV1↓ PIF↓ PEF↓ IC↔ TLC↓ RV↓ 
 MVV12↓
< 5 min
Zavorsky et al. [39] 2019 Marathon (42.2 km) N = 13 FVC↓  FEV1↓ PEF↓ ~ 25 min
Tiller et al. [38] 2019 Marathon (42.2 km, × 10) N = 9 (6 male) FVC↔  FEV1↑ PEF↔ MIP↔ MEP↓ < 15 min
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pre-to-post race, thereby discounting lower- and upper-
airway obstruction, respectively. Moreover, there was no 
evidence of airway obstruction on visual inspection of the 
MEFV curves. There was a significant post-race reduction in 
the maximum voluntary ventilation in 12 s  (MVV12), which 
led the authors to attribute their findings, at least in part, to 
a fall in respiratory muscle endurance. Collectively, these 
studies suggest that both marathon and ultra-marathon run-
ning is sufficient to induce substantial, albeit highly varied, 
reductions in pulmonary function, with or without the pres-
ence of airway obstruction, and which are likely to be influ-
enced by aspects of respiratory muscle fatigue.
There are several studies to the contrary, however, report-
ing limited evidence of a reduced pulmonary function fol-
lowing marathon or ultra-marathon running. In the early 
1980s, Loke et al. [34] showed no change in pre-to-post-
marathon vital capacity (VC), inspiratory capacity (IC) or 
 FEV1. A year later, pre- and post-marathon spirometric 
assessments were supplemented by additional measures of 
pulmonary and membrane diffusing capacity (DL,CO and 
DM, respectively) via the single-breath technique [35]. 
There was a post-race reduction in DL,CO (observations that 
have been confirmed elsewhere [36]), as well as decreases 
in DM and closing volumes (CV) associated with a decrease 
in lung recoil, which the authors speculated may have been 
due to a modest degree of pulmonary oedema. Neverthe-
less, there was no associated influence on lung capacity or 
flow rate. Research by Zavorsky et al. observed a modest 
2% decrease in post-marathon FVC, but no other changes 
in post-marathon indices of pulmonary function with the 
exception of a 12% decrease in alveolar membrane-diffusing 
capacity for carbon monoxide (DM,CO). When spirometry 
was performed by ten competitors at 3-h intervals through-
out a 24-h ultra-marathon, there was a steady decline in lung 
function as the challenge progressed, but without any of the 
reductions reaching statistical significance [37]. Finally, in 
a ten-marathon stage-race we recently showed no consist-
ent pre- to post-marathon decreases in FVC,  FEV1, or PEF, 
thereby alluding to the robustness of the healthy respiratory 
system to respond to multiple consecutive days of endurance 
stimuli [38].
The published literature, therefore, shows equivocal find-
ings with respect to pulmonary function following marathon 
and ultra-marathon running, but the reasons for such incon-
sistencies are unclear. There is considerable variation in the 
race distances and durations studied, including marathon 
(42.2 km, mean race time < 3 h 30 min), ultra-marathon 
ranging from 100 km (7 h 42 min) to 330 km (124 h 19 
min) in a single stage, and multi-stage races of up to 400 km 
(46 h). Moreover, although the specifics of the race environ-
ment were not always reported, this likely varied in terms of 
both terrain and cumulative elevation which, in turn, would 
influence exercise intensity, and there was no consistency 
in the magnitude or prevalence of the observed decrease in 
pulmonary function. Furthermore, despite a range in athlete 
ability and experience among studies, there does not appear 
to be any correlation between the magnitude of the post-race 
fall in FVC and marathon finish time [28]. A recent study in 
which post-race spirometric values were reduced by 19–24% 
found no difference in the magnitude or prevalence of the 
change between males and females, or between subjects who 
completed a full- or half-marathon [39]. The available studies 
report airway obstruction intermittently, and although airway 
obstruction did appear to be slightly more common following 
ultra-marathon, the limited number of studies make this diffi-
cult to interpret. Interestingly, respiratory muscle fatigue was 
sometimes reported without a concomitant decline in lung 
function, thus reinforcing the notion that the two phenomena 
are independent, but a decrease in pulmonary function was 
always explained with at least some evidence of respiratory 
muscle fatigue, airway obstruction, or both. A further consid-
eration is that there is variability with respect to the timing of 
post-race measures (range 5 min - 3 days). Exercise-induced 
decreases in pulmonary function are transient, and usually 
recover within a few hours of exercise cessation; as such, 
the literature is likely to be contaminated by non-significant 
findings from assessments made several hours or days post-
race. Finally, respiratory responses were recorded following 
marathons contested in the summer [29, 37, 38, 40], in warm 
conditions [41], below freezing [41], or in a temperature-
controlled laboratory [32], with no pattern in the post-race 
fall in pulmonary function. As a result, although decreased 
pulmonary function following marathon and ultra-marathon 
running is likely attributable to various combinations of air-
way obstruction, restriction, and respiratory muscle fatigue, 
further studies are needed to elucidate the specific external 
triggers for these mechanisms. Table 1 offers a summary of 
the pertinent studies and their main findings with respect to 
pulmonary function.
4.2  Respiratory Muscle Fatigue
Respiratory muscle fatigue is a phenomenon whereby the 
inspiratory and/or expiratory muscles exhibit a reduced 
force-generating capacity relative to baseline measures [42]. 
Respiratory muscle fatigue has been assessed objectively 
using magnetic nerve stimulation following high-intensity, 
exhaustive cycling, running, and arm-cranking [12, 43, 44], 
and indirectly using maximal volitional mouth-pressure 
manoeuvres following swimming and rowing time-trials 
[45, 46]. Until the early 1980s, few studies had assessed the 
prevalence of respiratory muscle fatigue in response to mara-
thon or ultra-marathon. There are now a number of reports 
of respiratory muscle fatigue under these conditions, the 
majority of which have used mouth-pressure manoeuvres 
as a surrogate for respiratory muscle force output, although 
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several have also used  MVV12 to estimate respiratory mus-
cle endurance. Mouth-pressure manoeuvres are considered 
a global measure of respiratory muscle strength [47]. The 
technique is reproducible [48], non-invasive, can be reported 
alongside well-established normative data, and – critically 
for the study of marathon and ultra-marathon running – can 
be applied easily in the field using a handheld device. A 
common limitation of the technique is that manoeuvres are 
volitional, dependent on athlete motivation, and might be 
subject to a practice effect; these factors should be consid-
ered when interpreting the following data.
One of the first studies to assess respiratory muscle 
strength in response to competitive marathon reported a sig-
nificant pre- to post-race fall in maximum inspiratory and 
expiratory mouth pressures of 16% and 28%, respectively 
[34]. The authors also reported a significant 20% fall in the 
peak transdiaphragmatic pressure elicited by IC manoeu-
vres, and a 10% reduction in respiratory muscle endurance 
assessed via  MVV12. Although these data were obtained 
from a small sample (n = 4), the findings have since been 
corroborated in larger samples, in which similar reductions 
in maximum inspiratory pressure (~15%) were observed (n 
= 21 [49]; n = 9 [32]). It is worth noting that both stud-
ies measured, but found no evidence of, expiratory muscle 
fatigue.
By contrast, there were no significant changes in pre- 
to post-race respiratory muscle strength immediately fol-
lowing an 87-km ultra-marathon [50], or at any stage of a 
24-h footrace during which assessments were made at 3-h 
intervals [37]; both studies observed post-race reductions 
in respiratory muscle endurance when assessed via inspira-
tory task-failure and  MVV12, respectively. It should be 
noted that the post-race assessments in the former study by 
Ker et al. [50] were made 3 days after the event, by which 
time any transient effects of exercise on respiratory muscle 
contractile function would likely have abated; it is possible, 
therefore, that they underestimated the degree of respira-
tory muscle fatigue. In an effort to assess the presence of a 
cumulative reduction in resting respiratory muscle strength, 
we recently assessed maximum static mouth-pressures peri-
odically throughout an ultra-marathon stage race comprising 
10 marathons in 10 consecutive days [38]. Contrary to our 
hypothesis, there was no baseline drift in respiratory muscle 
function. Moreover, there was no post-marathon decrease in 
maximum inspiratory muscle strength, although there were 
persistent pre- to post-marathon decreases in maximum 
expiratory muscle strength. Collectively, these data sug-
gest that inspiratory muscle fatigue is a common response 
to marathon running, whereas it may be that ultra-marathon 
running more readily provokes expiratory muscle fatigue.
Respiratory muscle work is a critical determinant of 
the magnitude of exercise-induced diaphragmatic fatigue 
[12, 13]. The running velocities typical of a single-stage 
marathon induce moderate-to-high levels of cardiorespira-
tory stress in the region of 60–75% V ̇O2max, depending on 
trained status[14]. Moreover, participants in published stud-
ies have recorded mean race times of < 3 h 30 min [32, 34], 
thus representing the 91st percentile. As such, those sub-
jects likely exhibited higher average ventilations than rec-
reational runners. By contrast, ultra-marathons, particularly 
those of extreme distance, necessitate that runners temper 
their race intensity in order to prioritise endurance for the 
latter stages of the event. Throughout an ultra-endurance 
stage race [38], this notion of preservation manifested in 
lower ratings of post-marathon dyspnoea (~ 2.0, Borg CR10 
scale) relative to those reported elsewhere during a single 
marathon competition (~ 12, Borg 6–20 scale [32]). As such, 
it may be that most long-distance ultra-marathons do not 
impose a sufficient ventilatory stimulus to provoke fatigue 
of the inspiratory muscles. By contrast, the major expira-
tory muscles (e.g., the rectus abdominis), adopt several non-
ventilatory roles during exercise, including postural support 
[51] and static contractions to increase thoracic pressure to 
stiffen the spine [52]. Moreover, the specific demands of 
ultra-marathon running (e.g., uneven terrain, long durations, 
carrying weighted backpacks) likely increase postural loads 
on the abdominals, thereby rendering them more susceptible 
to fatigue. Although the diaphragm also has a postural role, 
this is only coordinated with its respiratory functions during 
transient, intermittent disturbances to trunk stability (e.g., 
brief arm movements) [53]. Moreover, when humoral factors 
mediate ventilation (e.g., during sustained exercise), postural 
drive to the phrenic motoneurons is withdrawn and respira-
tory input is prioritised [54]. A diminished postural drive to 
the diaphragm, coupled with a modest ventilatory demand, 
would be a likely explanation for the lack of inspiratory 
muscle fatigue thus far noted in response to ultra-marathon 
running.
When interpreting the data on respiratory muscle function 
following marathon and ultra-marathon running, the time-
scale of recovery is an important consideration because it 
offers an insight into the contributing mechanisms. Stud-
ies that have assessed maximum mouth pressures pre- and 
post-marathon or ultra-marathon have noted: (1) significant 
reductions immediately post-race [35, 38]; (2) significant 
reductions at 2.5 h post-race [49]; (3) partial recovery at 
4 h post-race [32]; and (4) full recovery at 24 h post-race 
[32]. There are currently no published studies that report 
manifestations of respiratory muscle fatigue beyond 24 h 
post-race. Such a time-course of recovery is indicative of 
low-frequency, peripheral fatigue, the underlying mecha-
nisms of which are thought to be reduced  Ca2+ release from 
the sarcoplasmic reticulum, reduced  Ca2+ sensitivity of the 
myofibrils, and/or damaged sarcomeres caused by overexten-
sion of the muscle fibres [55]. Given that values are lowest 
immediately after exercise, and appear to partially recover at 
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4 h, the fatigue observed was likely due to reduced calcium 
release and/or sensitivity.
To date, only one study has assessed respiratory mus-
cle fatigue following ultra-marathon running using nerve 
stimulation techniques to artificially (and maximally) acti-
vate the respiratory muscles [40]. Direct induction of the 
phrenic nerves using this procedure is preferred to maximal 
static mouth-pressure manoeuvres because it results in an 
involuntary response from the respiratory muscles that is 
not influenced by participant motivation. Twenty-two expe-
rienced ultra-marathon runners completed a 110-km moun-
tain race with ~ 6000 m of positive elevation. Assessments 
made within 90 min of the finish demonstrated a signifi-
cant reduction in both maximum inspiratory and expiratory 
mouth pressures (16% and 21%, respectively), and a further 
19% reduction in the inspiratory mouth twitch-pressure fol-
lowing cervical magnetic stimulation. Given that there were 
only minor changes in post-race voluntary activation of the 
inspiratory muscles (i.e., the ratio between superimposed 
twitch amplitude and the subsequent mouth twitch-pressure), 
the authors proposed that fatigue of the inspiratory mus-
cles under these conditions was attributable to peripheral 
neuromuscular factors, as opposed to fatigue that was cen-
trally mediated. The observation of a significant fall in the 
inspiratory mouth twitch-pressure challenges the existing 
ultra-marathon literature, which has largely failed to observe 
such a fatigue of the inspiratory muscles. One explanation is 
the nature of the race contested (Ultra-trail du Mont-Blanc, 
Alps) which has strict qualifying standards, high eleva-
tion gain, and necessitates runners of exceptional ability 
and experience. As such, it is likely that the race induced 
substantial and sustained pulmonary ventilation, above-
and-beyond that observed in most other race types, thus, 
predicating the observed fatigue. Table 1 offers a summary 
of the pertinent studies and their main findings with respect 
to respiratory muscle function.
4.3  Thoracic Load Carriage
Marathons contested in remote locations (e.g., in the moun-
tains), and most ultra-marathons, require participants to run 
with backpacks that contain essential equipment including 
basic medical supplies, emergency clothing, and food. Sev-
eral studies have assessed the influence of weighted back-
packs on resting pulmonary function, observing significant 
reductions in both FVC and  FEV1 [56–58]. In an effort to 
elucidate the mechanisms underpinning these findings, 
Dominelli et al. [59] used oesophageal balloon catheters 
to assess intrathoracic pressures and respiratory mechanics 
during treadmill walking with backpacks of different masses. 
Relative to un-weighted backpacks, and a no-pack control, 
there was a progressive reduction in both FVC and  FEV1 
with increasing pack weight (15, 25, and 35 kg), a finding 
attributed to ribcage restriction caused by changes in chest-
wall compliance. A further observation was that heavier 
backpacks increased the work of breathing, although this 
was likely due to an increased minute ventilation second 
to elevated metabolic demands. Interestingly, there was no 
difference in FVC between the unweighted backpack and the 
no-pack control, suggesting that chest-straps alone do not 
influence lung capacity. Nevertheless, due to the presence 
of adequate ventilatory reserve, acute reductions in FVC are 
unlikely to hinder minute ventilation during exercise of a 
low ventilatory demand [59].
Notwithstanding the influence of weighted backpacks 
on pulmonary function, elevated thoracic loads may also 
influence the fatigability of respiratory muscles, although 
findings are inconsistent. Nadiv et al. [60] assessed the root 
mean square (RMS) amplitude and mean power frequency of 
the external intercostals and sternocleidomastoids during 1-h 
treadmill marching with, and without, a backpack weighing 
15 kg. The load resulted in a significant increase in EMG, 
suggesting a degree of fatigue with a central component. 
Nevertheless, these observations do not necessarily translate 
to diminished function, given that submaximal walking with 
backpack loads ranging from 0 to 20 kg have no influence 
on parameters of respiratory muscle strength [61]. Sixty 
minutes of brisk walking with a heavy backpack (25 kg), 
however, significantly reduced inspiratory and expiratory 
muscle strength by 11% and 13%, respectively. Values were 
further reduced to 16 and 19%, respectively, following a sub-
sequent 2.4-km time-trial [62]. Collectively, these data sug-
gest that heavier thoracic loads (i.e., > 20 kg) are necessary 
to influence respiratory muscle function during prolonged 
exercise, although studies using nerve stimulation techniques 
are needed to objectively corroborate these findings. It is 
worthy of consideration that, while certain military train-
ing regimens and ultra-endurance expeditions might require 
marching and running with backpacks weighing > 20 kg, the 
majority of marathons and ultra-marathons do not; as such, 
the influence of weighted backpacks on the magnitude and 
prevalence of respiratory muscle fatigue during these race 
types is likely minimal.
4.4  Implications for Health and Performance
There are several means by which reduced pulmonary func-
tion and/or respiratory muscle fatigue might impact on 
health or endurance running performance. First, the res-
piratory muscles have a critical role in maintaining torso 
stabilisation during exercise. The diaphragm, for example, 
contracts isometrically during repetitive postural tasks [63], 
and the major expiratory muscles contract to provide pos-
tural support [51] by increasing intra-abdominal pressure 
[52], thereby stiffening and stabilising the lumbar spine. 
This likely helps to protect spinal structures during periods 
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of postural disturbance. As a consequence, exercise that 
induces expiratory muscle fatigue might place the runner at 
a greater risk of injury, and render them less able to sustain 
the rigours of competition. Moreover, when considering the 
substantial exercise-induced reductions in calf and quadri-
ceps strength following ultra-marathon [64], a simultane-
ous respiratory and locomotor muscle fatigue may further 
increase the risk of fall and/or injury when traversing chal-
lenging terrain (e.g., a rocky or mountainous trail).
Second, the influence of lung function on marathon per-
formance was recently assessed in a sample of 110 mara-
thon runners [65]. Baseline spirometry was performed ~3 
days prior to a competitive marathon, after which runners 
were subcategorised by finish time. There were significant 
negative correlations between indices of pulmonary func-
tion and marathon finish time; i.e., faster marathon runners 
exhibited better metrics of lung function (FVC; r = − 0.41, 
p < 0.001:  FEV1; r = − 0.40, p < 0.001: PEF; r = − 0.50, 
p = 0.005). These data should be interpreted with care, 
inasmuch as there may be other reasons why runners with 
better lung function produced faster marathons; e.g., taller 
individuals (and those with larger lung capacities) are also 
likely to exhibit a longer stride length. Nevertheless, in an 
earlier study, Warren et al. [37] assessed lung function every 
3 h in competitors of a 24-h footrace. There were significant 
reductions in  MVV12 after 24 h, which were significantly 
related to the variance in running speed. The authors con-
cluded that the decrease in ventilatory muscle endurance 
might constrain running speed during extremely long ultra-
marathons. These studies provide interesting insights into 
lung function and its potential predictive power on endur-
ance running performance.
Finally, although a decrease in pulmonary function 
appears to be a common response to marathon and ultra-
marathon running, a pertinent question is whether such 
decreases reach levels of clinical importance (i.e., do post-
race values fall below the lower-limits of normal?). Given 
that the majority of studies do not address this question 
directly, those that reported significant post-race reductions 
in spirometric indices were collated and subjected to fur-
ther analyses. Of the initial eight studies, one did not report 
baseline function [66], and another reported mean data 
from subjects of various sexes, ethnicities, contesting both 
marathon and half-marathon [39], and the appropriate refer-
ence equation could not be discerned. For the six remaining 
studies, mean pre- to post-race data were analysed using 
the regression equations supplied by the Global Lung Func-
tion Initiative [67], and then compared to the most current 
population-specific reference values and their lower-limits of 
normal [68]. While care was taken to include the appropri-
ate participant demographics and to separate data obtained 
from male and female runners, this was not possible in only 
one study (1/3 female sample) due to the non-reporting of 
individual subject data [40]; in this instance, the reference 
values for males were used so that the data could be inter-
preted conservatively.
The findings from these analyses are shown in Table 2, 
and several conclusions were drawn: (1) the largest mean 
pre- to post-race decrease in pulmonary function (FVC + 
 FEV1) was exhibited following an ultra-marathon [29]. The 
subjects in that study exhibited baseline function that was 
slightly lower than that generally reported elsewhere (FVC 
= 5.0 L [94% predicted];  FEV1 = 3.79 L [87% predicted]); 
(2) immediately following the race, there was a significant 
decrease in both FVC (4.38 L [87% predicted]) and  FEV1 
(3.43 L [79% predicted]), both of which remained within 
an acceptable range of the lower-limit of normal (FVC 
= 4.27 L; FEV1 = 3.45 L). Relative to the other studies, 
these were the lowest post-race values when expressed as 
a percentage of predicted values (with the exception of 
Gordon et al., who only provided data on the FVC); (3) 
in all studies reassessed, the post-race  FEV1/FVC ratio 
remained within acceptable limits (range 0.78–0.85), and 
in only one of these studies was there a noteworthy increase 
in the ratio [28], suggesting a degree of restriction (i.e., 
greater expiratory flow rates relative to lung capacity); (4) 
the most robust post-race lung function was observed in 
those groups who exhibited the strongest baseline function. 
Given these observations, it is reasonable to suppose that 
the respiratory systems of trained runners are sufficiently 
robust to endure most race types, providing that athletes 
begin the race with a healthy resting function. Although 
speculative, the same magnitude of response in an indi-
vidual with below-average baseline parameters, or in an 
individual with a pre-existing respiratory disorder (e.g., 
asthma), may result in manifestations of clinical signifi-
cance. If such a scenario presents itself, some authors have 
suggested that runners requiring supplemental oxygen on 
the basis of respiratory distress should be disqualified 
from competition [21]. Accordingly, pre-event respiratory 
screening is recommended, particularly for individuals 
participating in events staged in remote and/or extreme 
environments where medical assistance may not be read-
ily available.
4.5  Limitations and Future Perspectives
There are limited data on acute pulmonary and respiratory 
muscle function following marathon and ultra-marathon, 
for several reasons. First, despite the growing popularity of 
ultra-marathon, participant numbers are still low relative to 
other sports. Moreover, runners are often reluctant to com-
promise their race preparation and/or recovery to volunteer 
for data-collection protocols, particularly when considering 
the long and arduous training necessary to compete. Sec-
ond, endurance races, particularly ultra-marathons, are often 
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contested in remote locations and environmental extremes, 
which do not lend themselves to complex or invasive data-
collection protocols requiring equipment that can be rarely 
transported. As a result, many of the studies included in the 
present review are restricted to basic spirometry and hand-
held mouth-pressure devices, which are convenient and 
easily-transportable but do not provide particularly mecha-
nistic insights. Moreover, given the transient nature of the 
post-race decreases in pulmonary and respiratory muscle 
function, complex procedures that take additional time to 
perform would rarely yield valid data. To gain a more com-
prehensive understanding of the pulmonary and respiratory 
muscle responses to marathon and ultra-marathon, there 
must be a drive to obtain more robust, high-quality data. 
This can be achieved by: (1) not spurning laboratory-based 
studies for fear of compromising ecological validity; (2) 
contriving to transport laboratory-based equipment into the 
field; and (3) using innovative study methodologies when 
neither of these former two can be achieved.
There are several pertinent areas of research that warrant 
further study. Decreases in pulmonary function following 
marathon and/or ultra-marathon have been reported with, 
and without, the presence of airway obstruction; further-
more, the magnitude of the response to any given race is 
highly variable. Accordingly, more research is needed to 
establish the characteristics that make runners susceptible to 
post-race decrements in pulmonary function. Where changes 
in function are observed, more data are needed to elucidate 
the causative mechanisms. There is also a growing body of 
research to suggest that marathon running may be associated 
with a mild and transient pulmonary oedema in up to half of 
all participants [10]; yet, to the author’s knowledge, there is 
but a single case-report of pulmonary oedema occurring in 
two runners following a 90-km ultra-marathon [69]. Further 
research is needed in this regard to elucidate the tolerabil-
ity to races of extreme distance and duration. With respect 
to respiratory muscle function, a majority of studies have 
inferred respiratory muscle fatigue using subjective (vol-
untary) mouth-pressure manoeuvres, with only one study 
revealing the mechanisms of action using objective nerve-
stimulation techniques [40]. More data are needed, specifi-
cally, to assess inspiratory and expiratory muscle fatigue 
following marathon/ultra-marathon running using magnetic 
stimulation of the phrenic and thoracic nerves. Finally, fur-
ther studies are needed to clarify whether targeted respira-
tory muscle training has the potential to offset respiratory 
muscle fatigue in response to endurance running, and the 
extent to which this might impact on performance.
5  Conclusion
Marathon and ultra-marathon appear sufficient to provoke 
reductions in pulmonary function in the range of 10–15%, 
with or without evidence of airway obstruction, and/or evi-
dence of respiratory muscle fatigue in the range of 15–25%. 
Although there are no data to suggest that the post-race 
decreases in pulmonary function are clinically significant, 
there might be more severe consequences for individuals 
with pre-existing respiratory disorders, and the available 
data highlight the importance of robust baseline parameters 
prior to participating in a marathon or ultra-marathon. Pre-
event respiratory screening is recommended, particularly for 
individuals participating in events staged in remote and/or 
extreme environments where medical assistance may not be 
readily available. The potential consequences of exercise-
induced respiratory muscle fatigue on endurance-running 
performance have been discussed. The conclusions drawn 
from this review might influence marathon and ultra-mar-
athon training and preparation strategies, as well as inform 
medical best-practice of personnel supporting the events 
(i.e., medics, race directors, and volunteers).
Table 2  Basic spirometry, for those studies reporting significant post-race reductions, reported alongside the predicted values and the lower-
limits of normal
FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, %Pred percentage of the predicted normal value, LL lower-limit of normal
*Value below the lower-limit of normal. NB, data from Wüthrich et al. comprised a 1/3 female cohort, with predicted values and lower-limits 
assumed for males
Author (s) Date Event FVC L (%Pred) FEV1 L (%Pred) FEV1/FVC (Pred)
PRE POST LL PRE POST LL PRE POST LL
Gordon et al. [25] 1924 Marathon (42.2 km) 4.3 (91) 3.5 (74)* 3.8 – – – – – –
Maron et al. [28] 1979 Marathon (42.2 km) 5.6 (106) 5.1 (97) 4.2 4.4 (102) 4.3 (99) 3.4 0.78 (0.82) 0.84 (0.82) 0.71
Mahler and Loke [29] 1981 Ultramarathon (100 km) 5.0 (94) 4.4 (82) 4.3 3.8 (87) 3.4 (79)* 3.5 0.76 (0.82) 0.78 (0.82) 0.71
Ross et al. [32] 2008 Marathon (42.2 km) 5.7 (104) 5.5 (99) 4.4 4.6 (103) 4.6 (102) 3.6 0.81 (0.82) 0.84 (0.82) 0.72
Wüthrich et al. [40] 2014 Ultramarathon (110 km) 4.2 (88) 4.1 (86) 3.8 3.8 (98) 3.5 (91) 3.0 0.90 (0.81) 0.85 (0.81) 0.70
Vernillo et al. [33] 2015 Ultramarathon (330 km) 5.2 (104) 4.7 (94) 3.9 4.1 (104) 3.7 (94) 3.1 0.80 (0.80) 0.80 (0.80) 0.69
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